Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(11;22)(q13;q11) IGL/CCND1

Written2018-01Jean-Loup Huret, Philippe Dessen

(Note : for Links provided by Atlas : click)

Identity

ICD-Topo C420,C421,C424 BLOOD, BONE MARROW, & HEMATOPOIETIC SYS
Atlas_Id 2825
Note Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this translocation, go to  How to contribute

Clinics and Pathology

Disease Mantle cell lymphoma|Mature B-cell neoplasm, NOS

Genes involved and Proteins

Gene NameIGL
Location 22q11.22
Gene NameCCND1
Location 11q13.3

Bibliography

Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes
Kawakami K, Miyanishi S, Sonoki T, Nakamura S, Nomura K, Taniwaki M, Murata T, Kadowaki S, Kadowaki N, Miura I
Int J Hematol 2004 Jun;79(5):474-9
PMID 15239399
 
A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene
Komatsu H, Iida S, Yamamoto K, Mikuni C, Nitta M, Takahashi T, Ueda R, Seto M
Blood 1994 Aug 15;84(4):1226-31
PMID 8049438
 


Translocations implicated (Data extracted from papers in the Atlas)

 t(11;22)(q13;q11) IGL/CCND1

External links

IGL (22q11.22) CCND1 (11q13.3)

Mitelman databaset(11;22)(q13;q11) [Case List]    t(11;22)(q13;q11) [Transloc-MCList] IGL/CCND1 [Fusion-MCList]
COSMICHisto = - Site = haematopoietic_and_lymphoid_tissue (COSMIC)
arrayMap (UZH-SIB Zurich)[select an item]
 
 
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed
All articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Aug 28 18:21:59 CEST 2018


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.